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Abstract
 
The transcription factor nuclear factor (NF)-
 
 
 
B has been suggested to be a key mediator of
the development of lymph nodes and Peyer’s patches. However, targeted deletion of NF-
 
 
 
B/
Rel family members has not yet corroborated such a function. Here we report that when
mice lacking the RelA subunit of NF-
 
 
 
B are brought to term by breeding onto a tumor ne-
crosis factor receptor (TNFR)1-deficient background, the mice that are born lack lymph
nodes, Peyer’s patches, and an organized splenic microarchitecture, and have a profound de-
fect in T cell–dependent antigen responses. Analyses of TNFR1/RelA-deficient embryonic
tissues and of radiation chimeras suggest that the dependence on RelA is manifest not in he-
matopoietic cells but rather in radioresistant stromal cells needed for the development of sec-
ondary lymphoid organs.
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Introduction
 
The microarchitecture of secondary lymphoid organs plays
an important role in facilitating the activation and matura-
tion of antigen-specific lymphocytes and ultimately the
mounting of an adaptive immune response (1). T cells are
primed by antigen-presenting cells in the T cell zones of the
periarteriolar lymphoid sheaths of the spleen, the paracortex
 
of LNs, and the dome area of Peyer’s patches (PPs)
 
*
 
 lining
the intestine. Primed T cells and antigen-activated B cells
then migrate into the primary follicles where they associate
with follicular dendritic cells (FDCs), giving rise to germinal
centers (GCs). Here, they undergo antigen-driven clonal
expansion and differentiation into plasma and memory cells.
 
Targeted gene deletion and radiation chimera analyses
have provided insights into the molecular machinery un-
derlying the development of secondary lymphoid organs,
emphasizing the importance of crosstalk between hemato-
poietic and nonhematopoietic cells. For example, RANK,
 
its ligand RANKL/TRANCE/OPGL, ROR
 
 
 
, TRAF6,
 
Id2, and the nuclear factor 
 
 
 
B–inducing kinase (NIK; as
 
implicated by the spontaneous mouse mutant 
 
aly
 
 [2]) appear
to be required to mediate signals important for the survival
and/or activation of a hematopoietic cell population in-
volved in LN development (3–10). NIK is also required to
mediate signals important for survival and/or activation of
a nonhematopoietic cell population at the LN anlage (10,
11). Signaling between the hematopoietic and nonhemato-
poietic cells relies on the interaction between the mem-
 
brane-bound cytokine LT
 
 
 
1
 
 
 
2
 
 on hematopoietic cells and
its receptor, LT
 
 
 
R, on nonhematopoietic cells (11–17).
PP development requires all of the same molecules, al-
though RANK and its ligand play a less significant role in
the development of these organs than they do in LN de-
velopment (3, 4, 6, 7, 9–12, 14, 15, 17). In addition, PP
development also relies to some extent on intercellular sig-
naling via TNF
 
 
 
 interaction with TNFR1 and intracellu-
lar signaling through I
 
 
 
B kinase 
 
 
 
 (IKK
 
 
 
) (18–22). Less is
known about the development of splenic structures: of the
molecules involved in lymph node development, only
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NIK, IKK
 
 
 
, LT
 
 
 
1
 
 
 
2
 
, and to a lesser degree TNF
 
 
 
 and
RANKL/TRANCE/OPGL have been shown to be re-
quired in hematopoietic cells, and NIK, IKK
 
 
 
, LT
 
 
 
R,
and to a lesser degree TNFR1 and RANK in nonhemato-
poietic cells (3, 5, 10, 12–15, 17, 19, 22–28).
A number of the aforementioned molecules rely on sig-
naling by members of the NF-
 
 
 
B/Rel family of transcrip-
tion factors. RANK, NIK, IKK
 
 
 
, TRAF6, LT
 
 
 
R, and
TNFR1 mediate cellular responses to extracellular signals
at least in part by activating NF-
 
 
 
B, and genes encoding
the cytokines RANKL/TRANCE/OPGL, TNF
 
 
 
, and
LT
 
 
 
 are targets of NF-
 
 
 
B–activated gene transcription.
Therefore, it has been hypothesized that NF-
 
 
 
B might
also play a role in the development of secondary lymphoid
organs.
NF-
 
 
 
B transcription factors are homodimeric and het-
erodimeric complexes of five family members: p50 (NF-
 
 
 
B1), p52 (NF-
 
 
 
B2), c-Rel, RelB, and RelA (p65).
Most cells contain only the complex p50/p65, held inac-
tive in the cytoplasm by association with I
 
 
 
B inhibitory
proteins. Activation of the cell leads to degradation of
I
 
 
 
B and nuclear translocation of NF-
 
 
 
B, resulting in the
transcription of multiple target genes (for reviews, see
references 29–32). Mice deficient for one or more of the
Rel family members have been generated (33–43), re-
vealing redundant and nonredundant roles for Rel pro-
teins in cell survival, hematopoiesis, and innate as well as
adaptive immune responses (for reviews, see references
44 and 45).
A role for NF-
 
 
 
B in the development of the splenic mi-
croarchitecture has been demonstrated by targeted dele-
tion and radiation chimera studies of p50 and p52: p50 is
required in hematopoietic cells for the formation of mar-
ginal zone (MZ) cells (46), and p52 is required in nonhe-
matopoietic cells for the formation of FDCs, GCs, and
MZ cells (36, 47). In contrast, a role for NF-
 
 
 
B in the de-
velopment of LNs or PPs has not yet been assigned. How-
ever, the importance of the Rel family member RelA in
the development of these structures has yet to be deter-
mined, because targeted disruption of RelA is lethal at
embryonic day 15 (E15) due to the absence of RelA-medi-
ated protection from TNFR1-signaled apoptosis in hepa-
tocytes (33, 48). We and others have generated mice
deficient for RelA by breeding the deficiency onto a
TNFR1-deficient background (49, 50). We report here
that LNs and PPs are absent and the splenic microarchitec-
ture is severely disorganized in TNFR1/RelA-deficient
mice, demonstrating a critical role for RelA in secondary
lymphoid organ development.
 
Materials and Methods
 
Histology.
 
Mice were killed by CO
 
2
 
 and the intestines and
mammary glands excised and fixed overnight in buffered forma-
lin or 70% ethanol/5% formaldehyde/5% acetic acid, respec-
tively. Tissues were embedded in paraffin, sectioned (4–6 
 
 
 
m
thick), stained with hematoxylin and eosin, and examined by
light microscopy.
 
Spleens and LNs were sectioned at 6 
 
 
 
m, mounted on slides,
and allowed to dry at room temperature for 5–10 min before
storing at 
 
 
 
20
 
 
 
C. At the time of staining, sections were fixed in
ice-cold acetone for 10 min, washed with PBS/0.1% Tween
(PBT), incubated 10 min in 3% H
 
2
 
O
 
2
 
/methanol if horseradish
peroxidase was to be used to visualize staining, and blocked for
15 min in PBT/5% BSA. They were then labeled for 1 h at 37
 
 
 
C
with one of the following primary reagents: anti-B220-biotin
(1:100; RA3–6B2; BD PharMingen), anti-CD3e-biotin (1:50;
145–2C11; BD PharMingen), anti-CR-1-biotin (8C12;
BD PharMingen), PNA-biotin (1:50; Vector Laboratories),
MOMA-1 (1:10; Serotec), anti-CD45.2-biotin (1:100; 104; BD
PharMingen). Labeling was detected using horseradish peroxi-
dase or alkaline phosphatase Vectastain ABC kits. Sections to be
stained for two antigens were washed well in PBT after staining
for the first antigen was complete, blocked with avidin and bi-
otin sequentially (Vector), and incubated with the next primary
reagent. All section were photographed at 10
 
 
 
 magnification
using digital imaging technology.
 
Flow Cytometry.
 
Embryonic intestines were harvested from
E17.5 fetuses, incubated in Collagenase D (Roche Laboratories)
for 1 h at 37
 
 
 
C, then passed twice through a 21-gauge needle,
twice through a 23-gauge needle, once through a 26-gauge nee-
dle, and filtered through a 70-
 
 
 
m strainer to make a single cell
suspension for use in flow cytometry.
Adult splenocytes were prepared by crushing spleens between
two glass slides and filtering through a 70-
 
 
 
m strainer. Cells
were plated in 1 ml complete RPMI (C10) at a density of 2 
 
 
 
10
 
6
 
 cells per well of a 24-well plate and stimulated for 18 h with
1 
 
 
 
g/ml anti-CD3e (145–2C11; BD PharMingen). After stimu-
lation, cells were scraped from the plate and washed three times
with FACS
 
®
 
 buffer to generate a single cell suspension for use in
flow cytometry.
For flow cytometric analysis, cells were first incubated with
Fc/block (anti-CD32/CD16) (FcgII/III Receptor, 2.4G2; BD
PharMingen) for 5 min. They were then incubated with combi-
nations of the following primary and secondary antibodies: anti-
CD4-phycoerythrin (RM4–5; BD PharMingen), anti-CD3
 
 
 
(145–2C11; BD PharMingen), anti-IL-7R
 
 
 
 (B12–1; BD Phar-
Mingen), anti-B220-biotin (RA3–6B2; BD PharMingen),
mLT
 
 
 
R-IgG1 (gift of Biogen Inc.), anti-LT
 
 
 
 (BBF6; Biogen
Inc.), streptavidin-FITC (BD PharMingen), streptavidin cy-
chrome (BD PharMingen), and anti–human IgG-FITC (Jackson
ImmunoResearch Laboratories).
 
RNA Analysis.
 
Embryonic intestines were harvested from
day E17.5 fetuses and snap frozen in liquid nitrogen. When all
tissue samples had been collected and frozen, samples were simul-
taneously thawed and homogenized with a Polytron homoge-
nizer (Brinkmann) in 1 ml TRIzol reagent (Molecular Research,
Inc.). Total RNA was extracted and precipitated as per manufac-
turer’s instructions.
1, 5, or 25 ng of total RNA was used as input for reverse tran-
scription (RT)-PCR (OneStep RT-PCR; QIAGEN) for ampli-
fication of LT
 
 
 
, LT
 
 
 
, RelA, TNFR1, or HPRT with the fol-
lowing primer combinations: (a) LT
 
 
 
: cacgaggtccagctcttttc,
agtgcaaaggctccaaagaa; (b) LT
 
 
 
: ggagcacaggctcagaaaag, gagct-
cagggttgaggtcag; (c) RelA: gagcccattggagttccagta, tgggggaaaact-
catcaaag; (d) TNFR1: accaagtgccacaaaggaac, cacgcactggaagtgt-
gtct; (e) HPRT ctttgctgacctgctggattt, aaccttaaccattttggggc.
 
Reconstitution of Bone Marrow with Fetal Liver Cells.
 
Radia-
tion chimeras were generated essentially as described (50).
Briefly, donor embryos were generated by crossing TNFR
 
 
 
/
 
 
 
RelA
 
 
 
/
 
 
 
 males to females and TNFR1
 
 
 
/
 
 
 
RelA
 
 
 
/
 
 
 
 males to fe- 
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males. Fetal livers were harvested from day 14.5 embryos, and
prepared and genotyped as described. Meanwhile, 6–8-wk-old
C57BL/6-CD45.1
 
 
 
 hosts were irradiated with two doses, 800
rads and 400 rads separated by 3 h, using a 
 
137
 
Cs source. Mice
were anesthetized with Avertin (2.5% solution of 2,2,2-tribro-
moethanol/tert amyl alcohol, 12 
 
 
 
l/g mouse) immediately after
the second irradiation and transplanted with 10
 
6
 
 liver cells from
wild-type, TNFR1-deficient, RelA-deficient, or TNFR1/RelA-
deficient fetuses in 200 
 
 
 
l medium by retro-orbital injection. The
extent of reconstitution was analyzed 4 mo after transplantation
by flow cytometry of one half of the spleen; 90–95% of the im-
mune system of each animal assayed was reconstituted with donor
hematopoietic cells (data not shown).
 
Immunoglobulin Isotype Analysis.
 
Sera were prepared from 4-wk-
old naive mice or mice that had been intraperitoneally im-
munized 1 wk before with alum-precipitated NP
 
7
 
CG (75 
 
 
 
g per
mouse). Immunoglobulin concentrations were quantitatively de-
termined using a sandwich ELISA by comparison to isotype stan-
dards (Southern Biotechnology Associates, Inc.). Briefly, plates
were coated with pan-specific capture antibody (for basal anti-
body measurements) or NP
 
23
 
BSA (for NP-specific response)
overnight at 4
 
 
 
C. The next day, they were washed with PBS/
0.05% Tween-20 and blocked for 1 h with PBS/1% BSA. Plates
were then washed again and incubated overnight at 4
 
 
 
C with sera
or isotype standards diluted in series in PBS/1% BSA/0.025%
Tween-20. Plates were washed the next morning and the con-
centration of immunoglobulin measured with isotype-specific
antibodies conjugated to horseradish peroxidase (Southern Bio-
technology Associates, Inc.).
 
Results
 
Basal and Specific Antibody Production in TNFR1/RelA-
deficient Mice.
 
Innate immune responses were previously
shown to be impaired in TNFR1/RelA-deficient mice
(50). To assess the ability of TNFR1/RelA-deficient mice
to mount an adaptive immune response, we measured basal
and specific antibody production. Basal Ig production was
determined by measuring the resting serum immunoglobu-
lin concentrations in unimmunized, age-matched wild-
type, TNFR1-, and TNFR1/RelA-deficient mice. All
classes of Ig were made by all animals but the quantitative
data showed that both TNFR1-dependent and TNFR1-
independent, RelA-dependent signaling pathways are in-
volved in the production of basal levels of most Ig isotypes
(Fig. 1 a).
To assay T cell–dependent response, age-matched wild-
type, TNFR1-, and TNFR1/RelA-deficient mice were
immunized with alum-precipitated NP
 
7
 
-CG. 7 d later, the
concentration of total (high and low affinity) NP-specific
antibodies in sera was measured by binding to densely NP-
haptenated bovine serum albumin (NP
 
23
 
BSA). Given the
sensitivity conferred upon this assay by using a highly hap-
tenated BSA, it was striking to find that no NP-specific
IgA, IgG1, IgG2a, IgG3, or IgM antibodies could be de-
tected in sera from TNFR1/RelA-deficient mice relative
to wild-type sera (Fig. 1 b); the only NP-specific antibody
that could be detected of those tested was IgG2b, and its
Figure 1. Severely reduced T cell–dependent antibody
response in TNFR1/RelA-deficient mice in vivo. (a) Basal
immunoglobulin concentrations. Serum was collected
from 3-wk-old wild-type (black circle), TNFR1-deficient
(gray circle), and TNFR1/RelA-deficient (open circle)
mice and immunoglobulin concentrations determined by
isotype-specific ELISA. (b) T cell–dependent antibody pro-
duction. 3-wk-old mice were immunized with NP-CG ad-
sorbed to alum and the level of NP-specific antibodies de-
termined 1 wk later by ELISA using NP-BSA as capture
antibody. Each point represents the mean of duplicate assays
from one animal; horizontal bars indicate mean concentra-
tion of the group. 
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concentration was 36-fold less in TNFR1/RelA-deficient
sera than in those from wild-type mice (Fig. 1 b). In con-
trast, the concentration of all NP-specific antibodies was el-
evated two- to threefold in sera from TNFR1-deficient
mice relative to wild-type sera with the exception of
IgG2a, which could not be detected in TNFR1-deficient
sera (Fig. 1 b). Thus, it appears that TNFR1-independent,
RelA-dependent signaling pathways play a critical role in
mounting T cell–dependent antibody responses by most
isotype classes of immunoglobulin.
 
Analysis of Secondary Immune Organs and Structures.
 
The
interactions between the various antigen-presenting cells
and lymphocytes that are required to mount a T cell–
dependent antibody response are facilitated by the organi-
zation of the LNs, PPs, and spleen. Therefore, these structures
were inspected in 3-wk-old wild-type, TNFR1-deficient,
and TNFR1/RelA-deficient mice. Inguinal, iliac, sacral,
mesenteric, axillary, lateral axillary, and cervical LNs were
readily observed in wild-type and TNFR1-deficient mice
by visual inspection. In contrast, although lymphatic vessels
were apparent, LNs could not be detected in TNFR1/
RelA-deficient mice (Fig. 2, a–f, and data not shown). In-
guinal LN or nodal remnants could not be detected in
TNFR1/RelA-deficient inguinal fat pads that had been
sectioned and hematoxylin and eosin (H & E) stained (Fig.
2, g and h), suggesting that LNs were truly absent rather
than reduced in size.
PPs were visible by dissecting microscopy only in wild-
type mice (Fig. 2, i–k). However, PPs were observable in
TNFR1-deficient mice after sectioning and H & E staining
of the intestine (Fig. 2, l and m; references 18 and 20). In
contrast, neither PPs nor PP remnants were visible in
stained serial sections of the intestines of three TNFR1/
RelA-deficient mice (Fig. 2 n), suggesting that TNFR1/
RelA-deficient mice lack these organs as well.
H & E staining of sections of wild-type, TNFR1-defi-
cient, and TNFR1/RelA-deficient spleens revealed that
the white pulp of TNFR1/RelA-deficient spleens was
markedly disorganized relative to the white pulp of wild-
type and TNFR1-deficient spleens (Fig. 3, a–c). To deter-
mine the extent to which the splenic microarchitecture
was altered in TNFR1/RelA-deficient spleens, 3-wk-old
mice were immunized with NP
 
7
 
-CG to induce GC for-
mation. Spleens were analyzed 1 wk later by immunohis-
tochemical labeling of T cell zones (anti-CD3) and B cell
follicles (anti-B220); FDCs (anti-CR-1) and GCs (PNA
 
 
 
);
and MZ resident B lymphocytes (anti-CR-1) and metal-
lophilic macrophages (anti–MOMA-1). Consistent with
previous results (18, 20, 25, 27, 28), TNFR1-deficient
spleens had clearly defined T cell zones (Fig. 3, e and k), B
cell follicles (Fig. 3, e and h), and MZs (Fig. 3, q and w),
However, B cell follicles appeared mildly reduced (Fig. 3
h), MZ B cell populations were mildly expanded (Fig. 3
q), the GCs were reduced in number and misplaced
around the central arteriole (Fig. 3 t), and FDCs were ab-
sent (Fig. 3, n and q). Like TNFR1-deficient spleens,
TNFR1/RelA-deficient spleens lacked FDCs (Fig. 3, o
and r); however, in contrast to TNFR1 mutants, TNFR1/
 
RelA-deficient spleens also lacked GCs (Fig. 3, o and u)
and MZs (Fig. 3, o, r, and x), and B and T cell zones ap-
peared smaller and intermixed around the central arteriole
(Fig. 3, f, i, and l).
 
Analysis of Embryonic Tissue for CD4
 
 
 
CD3
 
 
 
IL-7R
 
 
 
 
 
Cells.
 
A population of CD4
 
 
 
CD3
 
 
 
IL-7R
 
 
 
 
 
 cells is
present in embryonic tissues at the sites of LN and PP for-
mation that is believed to induce the development of these
secondary lymphoid organs (9, 51–53). To determine if
these cells were present in TNFR1/RelA-deficient em-
bryos, embryonic intestinal cells from E17.5 wild-type,
TNFR1-, and TNFR1/RelA-deficient mice were ana-
lyzed by flow cytometry. From 94 to 96% of these samples
were CD3
 
 
 
; of these, 1.85, 2.34, and 1.65% were CD4
 
 
 
IL-7R
 
 
 
 
 
 in wild-type, TNFR1-, and TNFR1/RelA-defi-
cient samples, respectively (Fig. 4). Thus, the CD4
 
 
 
CD3
 
 
 
IL-7R
 
 
 
 
 
 population was represented in embryonic intes-
tines of all genotypes, suggesting that the lack of LNs and
PPs in TNFR1/RelA-deficient mice is not due to the fail-
ure of this cell population to develop.
 
Analysis of Embryonic Tissue for Expression of LT
 
 
 
1
 
 
 
2
 
.
 
Expression of the membrane-bound cytokine LT
 
 
 
1
 
 
 
2
 
 is
required for the development of LN, PP, and all splenic
structures (for reviews, see references 54 and 55). To deter-
mine if LT
 
 
 
1
 
 
 
2
 
 is expressed by cells in TNFR1/RelA-
deficient embryos, we measured LT
 
 
 
 and LT
 
 
 
 expression
levels in E17.5 intestinal tissue by RT-PCR. LT
 
 
 
 and LT
 
 
 
levels were comparable in wild-type, TNFR1-deficient,
and TNFR1/RelA-deficient mice (Fig. 5). Consistent with
these results, similar levels of surface LT
 
 
 
/
 
 
 
 expression was
also observed in all three genotypes by flow cytometry us-
ing murine LT
 
 
 
R-Ig (unpublished data) (14, 56). These
results suggest that the absence of LNs and PPs in TNFR1/
RelA-deficient mice is not due to a decrease in the number
of cells expressing LT
 
 
 
1
 
 
 
2
 
 or in the level of LT
 
 
 
1
 
 
 
2
 
 ex-
pression by these cells.
 
LN Repopulation and Splenic Architecture in Radiation Chi-
meras.
 
An apparent absence of LNs and PPs could be due
to an intrinsic defect in the ability of hematopoietic cells to
home to or populate stromal structures. To determine if
this was true of TNFR1/RelA-deficient hematopoietic
cells, lethally irradiated C57BL/6 CD45.1
 
 
 
 wild-type hosts
were engrafted with CD45.2
 
 
 
 wild-type, TNFR1-, RelA-,
or TNFR1/RelA-deficient fetal liver cells and their im-
mune systems allowed to reconstitute for 4 mo. LNs of
these radiation chimeras were then assayed for the presence
of donor cells by immunohistochemical labeling of cryo-
sections for CD45.2
 
 
 
 donor populations. Labeling for
CD45.2 was comparably extensive in cryosections of LNs
harvested from mice reconstituted with all genotypes (Fig.
6, b and c); the absence of background staining was con-
firmed by labeling sections of LNs from untransplanted
hosts (Fig. 6 a). This demonstrates that TNFR1/RelA-defi-
cient hematopoietic cells can repopulate existing LNs as
well as wild-type hematopoietic cells, and suggests that the
absence of LNs and PPs is not due to an intrinsic defect in
the ability of TNFR1/RelA hematopoietic cells to home
to these organs. 
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Similarly, previous studies of radiation chimera models
have suggested that the absence of splenic structures could
be due to an intrinsic defect in the ability of hematopoi-
etic cells to induce their formation and maintenance (25,
57). To determine if the disrupted microarchitecture in
TNFR1/RelA-deficient spleens was due to a hematopoi-
etic cell-intrinsic defect in inducing these structures, the
spleens of the aforementioned radiation chimeras were an-
Figure 2. Absence of LNs and PPs in
TNFR1/RelA-deficient mice. Five 3-wk-old
wild-type (a, c, e, g, i, and l), TNFR1-deficient
(j and m) and TNFR1/RelA-deficient (b, d, f,
h, k, and n) mice were injected intraperito-
neally with Evans Blue (1 mg/ml, 20  l per
mouse) 18 h before dissection to visualize LNs
and PPs. (a and b) mesenteries; (c and d) lateral
axillary fossae; (e and f) inguinal fat pad; (g and
h) inguinal fat pad, sectioned and H & E-stained;
(i, j, and k) intestine whole mounts; (l, m, and
n) intestine, sectioned and H & E-stained. Ar-
rows indicate regions in which LNs and PPs
should be found. 15 additional mice of each
mutant genotype were inspected for the pres-
ence of these organs without prior injection of
Evan Blue; similar results were observed. 
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alyzed by immunohistochemical labeling. T cell zones
(Fig. 6, d–g), B cell follicles (Fig. 6, d–g), FDCs (Fig. 6,
h–o), GCs (Fig. 6, h–k, p–s), and MZs (Fig. 6, t-w) were
evident in spleens from radiation chimeras generated with
any type of donor population, suggesting that the
TNFR1/RelA-deficient hematopoietic cells are compe-
tent to induce splenic structures and that the absence of
splenic structures in TNFR1/RelA-deficient mice is
Figure 3. Aberrant organization of
lymphocytes and absence of secondary
immune response structures in TNFR1/
RelA-deficient spleens. 3-wk-old wild-
type (a, d, g, j, m, p, s, and v), TNFR1-
deficient (b, e, h, k, n, q, t, and w), and
TNFR1/RelA-deficient mice (c, f, i, l,
o, r, u, and x) were immunized with
NP7-CG and killed 1 wk later for analy-
sis of splenic structures. Two wild-type,
two TNFR1-deficient, and five
TNFR1/RelA-deficient spleens were
assayed. Sequential sections of spleen
were stained with (a–c) H & E; (d–l)
anti-B220 (brown) and/or anti-CD3
(purple); (m–u) anti-CR-1 (purple)
and/or PNA (brown); and (v–x)
MOMA-1 (purple). 
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therefore due to the absence of TNFR1 and/or RelA in
nonhematopoietic cell populations.
 
Discussion
 
We demonstrate here that TNFR1/RelA-deficient mice
lacked LNs, PPs, an organized splenic microarchitecture,
and T cell–dependent Ig responses. In contrast, TNFR1-
deficient mice lacked only a subset of splenic structures and
had relatively intact Ig responses. The disrupted architec-
ture of the TNFR1-deficient spleen demonstrates that
TNFR1 plays an important role in mediating the stimula-
tion of FDC and GC formation, a role which may or may
not rely on RelA activation. However, the more severe
phenotype of the TNFR1/RelA-deficient mice demon-
strates definitively that RelA plays an essential role in the
development of LNs, PPs, and splenic B cell follicles and
MZs, and that this role must be independent of signaling
through TNFR1.
Consistent with this, we observed that whereas NP an-
tigen-specific antibody production was largely normal in
TNFR1-deficient mice, it was profoundly reduced or ab-
sent in TNFR1/RelA-deficient mice. In contrast, basal
immunoglobulin production was only somewhat reduced
in both TNFR1- and TNFR1/RelA-deficient mice. This
demonstrates a significant defect in the T cell–dependent
antibody responses of TNFR1/RelA-deficient mice, and
suggests that this defect is due to the loss of RelA-depen-
dent transcription that is not induced by TNFR1. A simi-
lar defect in antibody production has been observed in
other mutant mice lacking LNs, PPs, and an organized
splenic microarchitecture (14, 17, 19, 58–61), thereby
providing corroborative evidence that organized lym-
phoid structures may play a minor role in determining
basal levels of Ig but are required to mount an antibody
response.
In which cells is RelA required? In the case of LN and
PP formation, this question is best addressed by assaying the
putative anlage sites for the presence of cells and proteins
known to be important in the development of these
organs. CD4
 
 
 
CD3
 
 
 
IL-7R
 
 
 
 
 
 hematopoietic cells were
present in TNFR1/RelA-deficient embryonic tissue, and
mRNA and protein levels of membrane-bound cytokine
LT
 
 
 
1
 
 
 
2
 
 in embryonic tissue were comparable to those in
wild-type tissue. This suggests that, in contrast to the Id2-,
LT
 
 
 
-, or LT
 
 
 
-deficient mice, the failure of TNFR1/
RelA-deficient mice to develop LNs and PPs is not due to
a defect in the ability of hematopoietic cells to induce non-
hematopoietic cells to promote the development of sec-
ondary immune organs.
The cellular requirement for RelA in the development
of splenic structures is best assessed by studying radiation
chimeras: in contrast to the development of LNs and PPs,
which occurs during a fixed window of embryogenesis (13,
62), the development of the splenic microarchitecture is
plastic through adulthood. We show here that B cells, T
cells, FDCs, GCs, and MZ cells were present and appropri-
ately organized in radiation chimeras generated with
TNFR1/RelA-deficient fetal liver cells, suggesting that
RelA is required in the nonhematopoietic cell compart-
Figure 4. Presence of CD4 CD3 IL-7R   cells in TNFR1/RelA-
deficient embryonic intestine. Flow cytometry was used to analyze intes-
tinal cells from E17.5 wild-type, TNFR1-deficient, and TNFR1/RelA
fetuses with the indicated cell-surface markers. All events presented are
negative for CD3. Each sample assayed consisted of tissue from three em-
bryos of the same genotype. Similar results were obtained from two inde-
pendent FACS® experiments.
Figure 5. Normal expression of LT 1 2 in TNFR1/RelA-deficient
embryonic intestine. RNA was prepared from E17.5 wild-type, TNFR1-
deficient, TNFR1/RelA-deficient intestines and assayed by RT-PCR for
expression of LT  and LT , RelA, TNFR1, and hprt (control). 
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ment for the development of an organized splenic micro-
architecture. We attempted to confirm this result by
performing reciprocal radiation chimera experiments, in
which wild-type hematopoietic cells were used as do-
nors to reconstitute the immune systems of irradiated wild-
type, TNFR1-deficient, and TNFR1/RelA-deficient mice.
However, TNFR1/RelA-deficient hosts consistently did
not survive more than 2 wk after radiation and transplanta-
tion, a time too short for reconstitution to be complete
(unpublished data).
While our radiation chimera experiments suggest that
RelA is required in nonhematopoietic cells for proper
Figure 6. Repopulation of
LNs and organization of spleen in
adoptive transfer mice reconsti-
tuted with TNFR1/RelA-defi-
cient hematopoietic cells.
C57BL/6 CD45.1  mice were
lethally irradiated and trans-
planted with wild-type, TNFR1-
deficient, RelA-deficient, or
TNFR1/RelA-deficient fetal
liver cells. 4 mo after transplant,
animals were killed and tissues
removed for cryosectioning.
LNs from one animal and
spleens from two animals of each
genotype were assayed. (a–c) In-
guinal LNs stained with donor-
specific anti-CD45.2 (brown).
(d–w) Sequential sections of
spleen stained with (d–g) anti-
B220 (brown) and/or anti-CD3
(purple); (h–s) anti-CR-1 (pur-
ple) and/or PNA (brown); and
(t–w) anti-MOMA-1 (purple). 
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spleen development, it should be noted that we and oth-
ers have also observed intrinsic defects in RelA-deficient
lymphocytes, i.e., a defect in the ability of TNFR1/
RelA- and RelA-deficient T and B cells to be activated
by polyclonal stimuli in vitro (unpublished data) (35,
63). Such an intrinsic cellular defect could, in principle,
contribute to the reduction in the T cell–dependent
immune response observed in TNFR1/RelA-deficient
mice. However, our analysis of splenic structures in ra-
diation chimeras suggests that these intrinsic defects do
not have a qualitative effect on the ability of TNFR1/
RelA-deficient cells to organize into structures in the
spleen. A more quantitative study will be required to as-
sess whether there is a measurable effect of these intrin-
sic defects on the size and organization of these struc-
tures.
Studies with other NF-
 
 B radiation chimeras have dem-
onstrated a similar nonhematopoietic cell requirement for
p52 in the formation of FDCs, GCs, and MZs (36, 47).
Given that the defect in secondary lymphoid organ devel-
opment in p52-deficient mice is limited to the spleen,
whereas that of TNFR1/RelA-deficient mice extends to
LNs and PPs as well, it is possible that p52/RelA het-
erodimers are responsible for the formation of splenic
structures, but that RelA heterodimerizes with other Rel
family members to fulfill a comparable role in stromal cells
of the LN and PP anlage.
Given that NF- B is known to either directly regulate
the expression of signaling molecules that have been impli-
cated in secondary lymphoid organ development or to reg-
ulate the expression of genes downstream of them, a num-
ber of potential roles for RelA can be envisioned in the
development of these structures. For example, the pheno-
type of the TNFR1/RelA-deficient mouse could be a syn-
thetic phenotype due to the deletion of TNFR1 combined
with the abrogation of RANK signaling as a result of the
absence of RelA activity. However, this is unlikely, as
TNFR1/RelA-deficient animals have normal numbers of
embryonic CD4 CD3 IL-7R   cells whereas these num-
bers are severely reduced in RANKL/TRANCE/OPGL-
deficient animals (5); in addition, RANK- and RANKL/
TRANCE/OPGL-deficient mice lack teeth (3, 4), which
TNFR1/RelA-deficient mice possess.
A more straightforward model is that RelA mediates
LT R signaling in nonhematopoietic cells. Targeted dele-
tion of LT R or disruption of signaling by LT R leads to
the absence of the same secondary organs and structures
that are absent in TNFR1/RelA-deficient mice. In addi-
tion, similar to our results, radiation chimera experiments
have demonstrated a requirement for LT R in nonhe-
matopoietic cells for the formation of secondary lymphoid
organs (64, 65). Finally, LT R mutant mice lack an anti-
body response to an extent that is comparable to that of the
TNFR1/RelA-deficient mice. Together, these results sug-
gest that the developmental phenotype observed in the
TNFR1/RelA-deficient mouse occurs because LT R-
mediated signaling to activate transcription in nonhemato-
poietic cells is genetically abrogated in the absence of
RelA.
What could be the importance of RelA-mediated tran-
scription activity? LT R is a member of the TNF super-
family of receptors which, like TNFR1, not only activates
NF- B during signaling (66) but also mediates cytotoxic
responses in some cell lines (67, 68). It is possible that, sim-
ilar to its role downstream of TNFR1, RelA is acting
downstream of LT R and its activation provides protec-
tion against the cytotoxic effects of LT R-mediated signal-
ing; in the absence of RelA, LT R-expressing stromal cells
would die instead of develop into secondary lymphoid or-
gans. However, MEFs generated from RelA-deficient and
TNFR1/RelA-deficient embryos were as viable as wild-
type and TNFR1-deficient MEFs after treatment with
concentrations of mLT   that have proven cytotoxic to
several cell lines (unpublished data). Thus, either RelA
does not play an antiapoptotic role after LT R stimulation,
or the responses of mouse embryonic fibroblasts are not
representative of the responses of stromal cells expressing
LT R in vivo.
We have observed that stromal cells of the lung require
RelA to produce chemokines and cell adhesion molecules
in response to LPS (50). Similarly, RelA might play a role
in secondary lymphoid development by inducing the ex-
pression of chemokines and cell adhesion molecules that
are necessary for trafficking hematopoietic cells to anlage
sites. For example, NF- B regulates the expression of vas-
cular cell adhesion molecule (VCAM)-1 (69), which is ex-
pressed on clusters of cells that mark embryonic sites for PP
development (70) and can be induced in fibroblasts by
stimulation of LT R with mLT   (11). NF- B also regu-
lates the expression of two genes that are transiently ex-
pressed in the high endothelial venules of developing LNs:
intercellular adhesion molecule (ICAM)-1 (71–73), which
promotes adhesion between leukocytes and endothelium,
and the mucosal vascular addressin cell adhesion molecule
(MadCAM)-1 (74), which interacts with homing receptors
on lymphocytes and monocytes (75, 76). More extensive
analysis of gene and protein expression during lymphoid
organ formation will reveal if the expression of these and
other molecules is changed in the absence of RelA, provid-
ing further insights into the role of RelA in the develop-
ment of secondary lymphoid organs.
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